Stomach Cancer: Clinical Trials

12 trials for Stomach Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 unknown, 2 recruiting, 1 terminated. 12 Phase 3, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 312Completed 5, Unknown 3, Recruiting 2, Terminated 1, Withdrawn 1
Phase 25Completed 2, Recruiting 2, Terminated 1

Follow Stomach Cancer: new trials by email Literature Review of Stomach Cancer trials Research Report on Stomach Cancer

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer
Docetaxel, Oxaliplatin, Leucovorin - Gastric Cancer, Stomach Cancer
Phase 2 / Phase 3RecruitingUkrainian Society of Clinical Oncology1502025-03-252025-05-06
KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy
KN026/Placbo Injection, Paclitaxel Injection, Docetaxel Injection - Stomach Cancer
Phase 2 / Phase 3RecruitingShanghai JMT-Bio Inc.2862022-04-072023-12-19
HX008 Plus Irinotecan Versus Placebo Plus Irinotecan as Second-line Treatment in Advanced Gastric Cancer
Irinotecan Hydrochloride Injection, HX008, Placebo - Stomach Cancer
Phase 3UnknownTaizhou Hanzhong biomedical co. LTD5602020-09-162021-01-28
Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer
nab paclitaxel, Tegafur, Oxaliplatin - Stomach Cancer
Phase 3UnknownZhejiang Cancer Hospital6162020-03-012020-03-23
FLOT vs. FLOT/Herceptin/Pertuzumab for Perioperative Therapy of HER-2 Expressing Gastric or GEJ Cancer
FLOT alone, FLOT + Herceptin/Pertuzumab - Stomach Cancer, Gastroesophageal Junction Cancer
Phase 2 / Phase 3CompletedInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest812016-06-012020-08-11
FLOT vs. FLOT/Ramucirumab for Perioperative Therapy of Gastric or GEJ Cancer (RAMSES)
Docetaxel, Oxaliplatin, Calciumfolinat - Stomach Cancer, Gastroesophageal Junction Cancer
Phase 2 / Phase 3CompletedInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1802016-06-012022-07-11
The Use of Ultrasonic Coagulating Shears Compared to Monopolar Electrocautery in Open Gastric Cancer Surgery
Ultrasonic Coagulating Shears - Stomach Cancer, Gastrectomy
Phase 3UnknownSamsung Medical Center2562010-01-012010-12-16
Comparison Study for Bile Reflux and Gastric Stasis in Patients After Distal Gastrectomy
Billroth-II (B-II), Roux en Y gastrojejunostomy (RY-GJ), uncut Roux en Y gastrojejunostomy - Stomach Cancer, Gastrectomy
Phase 3WithdrawnThe Catholic University of Korea902007-07-012009-08-03
A Study of Vinflunine in Patients With Gastric Cancer
Vinflunine - Stomach Cancer
Phase 2 / Phase 3TerminatedBristol-Myers Squibb552007-03-012010-03-02
Metastatic Gastric Cancer FFCD 03-07
ECC, FOLFIRI - Stomach Cancer, Neoplasm Metastasis
Phase 3CompletedUniversity Hospital, Toulouse4162005-06-012011-10-12
Trial of Adjuvant Chemotherapy for Gastric Cancer
Mitomycin, doxifluridine and cisplatin, Mitomycin and doxifluridine - Stomach Cancer
Phase 3CompletedAsan Medical Center8552002-02-012014-02-27
Trial of Adjuvant Chemotherapy for Gastric Cancer
cisplatin, mitomycin-C, doxifluridine - Stomach Cancer
Phase 3CompletedAsan Medical Center5282001-10-012020-01-18

Narrower conditions

Stomach Neoplasms (12)  ·  Gastrointestinal Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Postgastrectomy Syndromes (1)

Broader conditions

Digestive System Diseases (12)  ·  Digestive System Neoplasms (12)  ·  Gastrointestinal Diseases (12)  ·  Neoplasms by Site (12)  ·  Stomach Diseases (12)  ·  Gastrointestinal Neoplasms (11)  ·  Neoplasms (11)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Neoplastic Processes (1)  ·  Postoperative Complications (1)

Interventions

Docetaxel (3)  ·  Oxaliplatin (3)  ·  Cisplatin (2)  ·  Fluorouracil (2)  ·  Irinotecan (2)  ·  Leucovorin (2)  ·  Mitomycin (2)  ·  doxifluridine (2)  ·  Albumin-Bound Paclitaxel (1)  ·  Capecitabine (1)  ·  Gastric Bypass (1)  ·  Gastroenterostomy (1)  ·  IFL protocol (1)  ·  Paclitaxel (1)  ·  Ramucirumab (1)

Sponsors

Asan Medical Center (2)  ·  Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest (2)  ·  Bristol-Myers Squibb (1)  ·  Samsung Medical Center (1)  ·  Shanghai JMT-Bio Inc. (1)  ·  Taizhou Hanzhong biomedical co. LTD (1)  ·  The Catholic University of Korea (1)  ·  Ukrainian Society of Clinical Oncology (1)  ·  University Hospital, Toulouse (1)  ·  Zhejiang Cancer Hospital (1)

Countries

South Korea (5)  ·  China (3)  ·  Germany (2)  ·  France (1)  ·  Italy (1)  ·  Lithuania (1)  ·  Malaysia (1)  ·  Philippines (1)  ·  Ukraine (1)

Top investigators

Salah-Eddin Al-Batran, Prof. Dr. (2)  ·  Yoon-Koo Kang, M.D.,Ph.D. (2)  ·  Jae Moon Bae, MD., Ph.D. (1)  ·  Mykyta Pepenin, MD (1)  ·  Wook Kim, MD, PhD (1)

Results publications

PMID 25287828, PMID 33435909, PMID 35709415, PMID 36883420